A Study Assessing Repatha® in Combination With Standard of Care (SOC) Compared With SOC on Major Cardiovascular Events in Chinese Participants With Atherosclerotic Cardiovascular Disease
Clinical trial NCT06295679 · RECRUITING
Trial details
- NCT number
- NCT06295679
- Sponsor
- Amgen
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2022-12-19
- Primary completion
- 2028-12-19
- Enrollment
- 7000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.